Basic Information
ID: ALA5148111
Type: Binding
Description: Inhibition of survivin dimerization in human LNCaP C4-2 cells assessed as survivin degradation at 500 nM incubated for 24 hrs after 2 hrs pretreatment with proteasome inhibitor bortezomib by Western blot analysis
Organism: Homo sapiens
Cell type: LNCaP C4-2
Activity Charts
Bioactivity
Activity Types for Assay ALA5148111
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 224.18 | 1.22 | 1.22 |